Self-amplifying RNA virus vectors for drug delivery.

Area of Science:

• Biotechnology
• Virology
• Immunology

Background:

• Viral vectors are crucial for delivering genetic material for therapeutic and prophylactic applications.
• Self-amplifying RNA viruses enable high-level RNA amplification in host cell cytoplasm, leading to robust antigen production.

Purpose of the Study:

• To review the applications and efficacy of self-amplifying RNA viral vectors.
• To summarize findings from animal models and clinical trials regarding immune responses and therapeutic outcomes.

Main Methods:

• Literature search of PubMed and clinical trial/biotechnology company websites up to September 2024.
• Analysis of studies evaluating self-amplifying RNA viral vectors in preclinical and clinical settings.

Main Results:

• Self-amplifying RNA viruses induce strong immune responses and vaccine efficacy, exemplified by the approved Ebola virus vaccine.
• Demonstrated therapeutic and prophylactic efficacy in animal tumor models and cancer patients.
• Exploration of self-amplifying RNA viruses for neurological disorder treatment in mouse models.

Conclusions:

• Self-amplifying RNA viral vectors show significant promise for infectious disease vaccines and cancer therapies.
• Their ability to elicit potent immune responses supports their continued development and application.